| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/2004 | WO2004029091A2 FVII OR FVIIa VARIANTS HAVING INCREASED CLOTTING ACTIVITY |
| 04/08/2004 | WO2004029090A1 Human coagulation factor vii polypeptides |
| 04/08/2004 | WO2004029089A2 Novel angiogenesis target and uses thereof |
| 04/08/2004 | WO2004029087A2 Bitter taste receptors |
| 04/08/2004 | WO2004029081A2 Modified glp-1 peptides with increased biological potency |
| 04/08/2004 | WO2004029080A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 04/08/2004 | WO2004029075A2 Peptide nucleic acids having improved uptake and tissue distribution |
| 04/08/2004 | WO2004029074A2 Hiv-derived hr1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 04/08/2004 | WO2004029073A2 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 04/08/2004 | WO2004029072A2 PrPsc -INTERACTING MOLECULES AND USES THEREOF |
| 04/08/2004 | WO2004029071A2 Mage-c2 antigenic peptides and uses thereof |
| 04/08/2004 | WO2004029023A2 Cell-surface estrogen receptor and related compositions and methods |
| 04/08/2004 | WO2004028578A1 Composition for stimulating bone-formation and bone consolidation |
| 04/08/2004 | WO2004028566A1 Pharmaceutical composition for prevention and treatment of kidney diseases |
| 04/08/2004 | WO2004028561A1 Method of inducing immune responses |
| 04/08/2004 | WO2004028559A1 Anti-angiogenic fragments of pigment epithelium-derived factor (pedf) |
| 04/08/2004 | WO2004028557A1 Stabilized protein compositions |
| 04/08/2004 | WO2004028556A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 04/08/2004 | WO2004028555A1 Resistin binding proteins, their preparation and use |
| 04/08/2004 | WO2004028554A2 Skrp, astray, string, vacm associated with metabolic control |
| 04/08/2004 | WO2004028553A1 A method of modulating cellular development |
| 04/08/2004 | WO2004028552A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | WO2004028551A1 Novel agents that modulate eph receptor activity |
| 04/08/2004 | WO2004028546A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | WO2004028537A1 Use of thiazolidinedione derivatives as aldose reductase inhibitors |
| 04/08/2004 | WO2004028521A2 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 04/08/2004 | WO2004028516A2 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases |
| 04/08/2004 | WO2004028481A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004028474A2 Caspase inhibitors as anticancer agents |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | WO2004028472A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
| 04/08/2004 | WO2004028471A2 Influenza therapeutic |
| 04/08/2004 | WO2004028469A2 Docohexaenoic acid for improved glycemic control |
| 04/08/2004 | WO2004028468A2 Methods and compositions for treatment of neurological disorder |
| 04/08/2004 | WO2004028466A2 Ketoamide inhibitors in chronic nerve disease |
| 04/08/2004 | WO2004028465A2 Hemostatic compositions and methods |
| 04/08/2004 | WO2004028457A2 PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY |
| 04/08/2004 | WO2004028444A2 Parathyroid hormone antagonists and uses thereof |
| 04/08/2004 | WO2004028339A2 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 04/08/2004 | WO2004028239A2 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 04/08/2004 | WO2004018499A3 Synthetic heparin-binding growth factor analogs |
| 04/08/2004 | WO2004015096A3 Leech extracts for stents |
| 04/08/2004 | WO2004014396A9 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |
| 04/08/2004 | WO2004011624A9 Double stranded rna structures and constructs, and methods for generating and using the same |
| 04/08/2004 | WO2004009619A3 Protein complexes of the tip60 transcriptional activator protein |
| 04/08/2004 | WO2004009124A3 Ghrelin-carrier conjugates |
| 04/08/2004 | WO2004009072A3 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 04/08/2004 | WO2004007764A3 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/08/2004 | WO2004005467A3 Expression of human interferon in transgenic chloroplasts |
| 04/08/2004 | WO2004005339A3 Cationic linear peptides having antibacterial and/or antifungal properties |
| 04/08/2004 | WO2004004687A3 Liposomal vaccine |
| 04/08/2004 | WO2004004643A3 Interferon gamma in the detection and treatment of angiomyolipomas |
| 04/08/2004 | WO2004004551A3 Alpha-melanocyte stimulating hormone peptides protection in organ transplantation |
| 04/08/2004 | WO2004003016A3 Marked peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004003015A3 Peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004003006A3 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2003106619A3 Multifunctional polypeptides |
| 04/08/2004 | WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/08/2004 | WO2003103709A3 Cd200-receptor mediated modulation of bone development |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003102185A3 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
| 04/08/2004 | WO2003101387A3 Globulin protein to lower cholesterol in humans |
| 04/08/2004 | WO2003100433A3 Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003099207A3 Oral lactoferrin in the treatment of respiratory disorders |
| 04/08/2004 | WO2003095482A3 Novel cyclic peptides and use thereof as anti-microbial agents |
| 04/08/2004 | WO2003094617A3 Use of vegf for treating bone defects |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003090771A3 Diagnostics and therapeutics for diseases associated with trace amine receptor 3(ta3) |
| 04/08/2004 | WO2003089000A3 Anti-hiv composition, production method thereof and medicament |
| 04/08/2004 | WO2003087144A3 Insecticide proteins from photorabdus luminescens |
| 04/08/2004 | WO2003087122A3 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| 04/08/2004 | WO2003084979A3 Novel peptides and the application thereof in therapy |
| 04/08/2004 | WO2003084611A8 Depsipeptide for therapy of kidney cancer |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003081246A8 Treatment of congestive heart failure with natriuretic peptide and a diuretic |
| 04/08/2004 | WO2003080646A3 Modified plasminogen activator inhibitor type-1 and methods based thereon |
| 04/08/2004 | WO2003077852A3 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β |
| 04/08/2004 | WO2003076585A3 Controlled modulation of amino acid side chain length of peptide antigens |
| 04/08/2004 | WO2003074060A3 Dna demethylase antisense and chemotherapy combination |
| 04/08/2004 | WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/08/2004 | WO2003070083A3 Endothelial precursor cells for enhancing and restoring vascular function |
| 04/08/2004 | WO2003068922A3 Compositions and methods for treatment of osteoarthritis |
| 04/08/2004 | WO2003068921A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003061728B1 Oral administration of interferon-tau |
| 04/08/2004 | WO2003059262A3 Method and composition for treating and preventing hiv infection and aids |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers |
| 04/08/2004 | WO2003038112B1 A composition and method to alter lean body mass and bone properties in a subject |
| 04/08/2004 | WO2003035683A8 Surfactant protein-d and atherosclerosis |
| 04/08/2004 | WO2003019457A3 Method of optimizing growth hormone replacement |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2003017817A3 Diagnosis, prevention and treatment of cancer |
| 04/08/2004 | WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/08/2004 | WO2003012030A3 Isoform-selective inhibitors and activators of pde3 cyclic |